Alternative image

June 23, 2026

Evonik optimizes methanol supply for its methionine production network in Europe

  • Evonik and regional partners now share infrastructure 
  • New methanol pipeline from Lülsdorf to Wesseling  
  • Synergies and improved carbon footprint of methanol 

Essen, Germany. As part of strengthening its long-term raw material strategy, Evonik has developed a new solution to secure the methanol supply needed for producing a methionine precursor at its Wesseling site. The concept was implemented together with Lülsdorf Functional Solutions GmbH, Röhm GmbH, and the experts for infrastructure from SYNEQT Pipelines. Building on existing infrastructure, the partners complemented it with a new long-distance pipeline between Lülsdorf and Wesseling, which went into operation in June 2026.

“This joint solution helps us in three ways: It secures the long-term methanol supply for our Wesseling site, it reduces Scope 3 emissions, and it opens the opportunity to buy green methanol in the future,” says Norbert Steier, head of Production and Technology for Evonik's Animal Nutrition business line. Evonik invested a high single-digit-million-euro amount in the project.

Group photo (from left to right): Ch. Schindler (Röhm), A. Selbach (SYNEQT), G. Baer (Deputy District Administrator), R. Manzke (Mayor of Wesseling), M. Surjanto (Evonik), F. Heßing (SYNEQT), N. Steier (Evonik), G. Blanda (Evonik), U. Bindernagel (Lülsdorf Functional Solutions)

Alternative image

To make the new setup possible, Evonik and its partners are using shared regional storage and logistics infrastructure. Methanol is imported via Lülsdorf and transported directly to Wesseling through the new pipeline, ensuring a competitive and reliable supply for both Evonik and Röhm.

In the future, Evonik will use methanol based on natural gas. Its CO₂ footprint will be about 70 percent lower than that of the crude-oil-based methanol previously used by the company.

Evonik needs methanol for the production of methylmercaptopropionaldehyde (MMP). MMP from Wesseling is one of the starting materials for the production of MetAMINO® (DL‑methionine) at Evonik's Antwerp site in Belgium. The new methanol infrastructure strengthens the Animal Nutrition business line’s strategy to ensure long-term supply security for its customers through its three global methionine production hubs.

MetAMINO® is used in livestock production to feed animals healthily, efficiently, and sustainably. With its science-based approach, the Animal Nutrition business line develops products, services, and system solutions that help supply a growing world population with healthy, high-quality, and affordable animal protein.

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

About Advanced Technologies

The Advanced Technologies segment includes Evonik’s market-leading businesses that leverage technological expertise and process know-how. These businesses feature high-performance polymers and crosslinking agents, hydrogen peroxide and silica, as well as feed ingredients. In 2025, the segment generated sales of €5.9 billion with around 9,200 employees.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.